Ambra BioScience - Lovidia
Ambra BioScience - Lovidia

Ambra BioScience - Lovidia Information

Contact top employees from Ambra BioScience - Lovidia

Summary

Ambra BioScience - Lovidia is a private company. The company currently specializes in the Biotechnology area. Its headquarters is located at San Diego, California, USA. The Ambra BioScience - Lovidia annual revenue is estimated at < 1M. Total funding of the company - $650K. To connect with Ambra BioScience - Lovidia employee register on SignalHire.

Organization Website

ambrabio.com

Industries

Headquarters Location

1850 Diamond St, San Marcos, California, 92078 US

Employees Size

10-50 employees

Specialties

Advancement of the science of Gut Sensory Modulation (GSM) to facilitate the development of medical foods and dietary supplements that work naturally with the digestive system to improve health.

DMA Code

San Diego County

Founded

2014

Operating Status

Independent Company

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Ambra BioScience - Lovidia shows a diverse range of experience levels:
25% for 5–7 years50% for 8–10 years25% have over 11 years of service at Ambra BioScience - Lovidia
Contact top employees from Ambra BioScience - Lovidia

FAQ

Ambra BioScience - Lovidia operates in the Biotech industries. More details can be found on the official website: ambrabio.com.
The headquarters of Ambra BioScience - Lovidia are located in San Marcos, United States.
Ambra BioScience - Lovidia currently employs 10-50 people.
Ambra BioScience - Lovidia's revenue is approximately < 1M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP